A global phase Ill multicenter, randomized, double arm, open label trial of ASP-1929 photoimmunotherapy versus physician's choice standard of care for the treatment of patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).

被引：7
|
作者：
Biel, Merrill A.
Gillenwater, Ann M.
Cognetti, David M.
Johnson, Jennifer Maria
Argiris, Athanassios
Tahara, Makoto
机构：
[1] Rakuten Aspyrian Inc, San Diego, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[4] Hygeia Hosp, Maroussi, Greece
[5] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[6] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.TPS6094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS6094
引用
收藏
页数：1
相关论文
共 44 条
  • [1] Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).
    Cognetti, David M.
    Johnson, Jennifer Maria
    Curry, Joseph M.
    Mott, Frank
    Kochuparambil, Samith Thomas
    McDonald, Darren
    Fidler, Mary J.
    Stenson, Kerstin
    Vasan, Nilesh R.
    Razaq, Mohammad
    Campana, John P.
    Biel, Merrill A.
    Gillenwater, Ann M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
    Cognetti, David M.
    Johnson, Jennifer M.
    Curry, Joseph M.
    Kochuparambil, Samith T.
    McDonald, Darren
    Mott, Frank
    Fidler, Mary J.
    Stenson, Kerstin
    Vasan, Nilesh R.
    Razaq, Mohammad A.
    Campana, John
    Ha, Patrick
    Mann, Grace
    Ishida, Kosuke
    Garcia-Guzman, Miguel
    Biel, Merrill
    Gillenwater, Ann M.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (12): : 3875 - 3887
  • [3] A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
    Makoto Tahara
    Susumu Okano
    Tomohiro Enokida
    Yuri Ueda
    Takao Fujisawa
    Takeshi Shinozaki
    Toshifumi Tomioka
    Wataru Okano
    Merrill A. Biel
    Kosuke Ishida
    Ryuichi Hayashi
    International Journal of Clinical Oncology, 2021, 26 : 1812 - 1821
  • [4] A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
    Tahara, Makoto
    Okano, Susumu
    Enokida, Tomohiro
    Ueda, Yuri
    Fujisawa, Takao
    Shinozaki, Takeshi
    Tomioka, Toshifumi
    Okano, Wataru
    Biel, Merrill A.
    Ishida, Kosuke
    Hayashi, Ryuichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (10) : 1812 - 1821
  • [5] A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
    Kiyota, Naomi
    Hasegawa, Yasuhisa
    Takahashi, Shunji
    Yokota, Tomoya
    Yen, Chia-Jui
    Iwae, Shigemichi
    Shimizu, Yasushi
    Hong, Ruey-Long
    Goto, Masahiro
    Kang, Jin-Hyoung
    Li, Wing Sum Kenneth
    Ferris, Robert L.
    Gillison, Maura
    Namba, Yoshinobu
    Monga, Manish
    Lynch, Mark
    Tahara, Makoto
    ORAL ONCOLOGY, 2017, 73 : 138 - 146
  • [6] A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck
    Bossi, P.
    Merlano, M. C.
    Ghi, M. G.
    Rinaldi, G.
    Caponigro, F.
    Morelli, F.
    Airoldi, M.
    Farnesi, A.
    Cassano, A.
    Ferrari, D.
    Mirabile, A.
    Tosoni, A.
    Galizia, D.
    Moretti, G.
    Sponghini, A. P.
    Calareso, G.
    Vingiani, A.
    Perrone, F.
    Falletta, A.
    Licitra, L. F.
    ANNALS OF ONCOLOGY, 2019, 30 : 463 - 463
  • [7] Petosemtamab compared with investigator's choice monotherapy in previously treated patients (pts) with recurrent/metastatic (r/m) head and neck squamous cell carcinoma (HNSCC): A randomized, open-label, phase III trial
    Haddad, R.
    Gillison, M.
    Harrington, K. J.
    Kim, S-B.
    Le Tourneau, C.
    Rosenberg, A.
    Ford, J.
    Shen, Y-M.
    Yao, D.
    Zohren, F.
    Machiels, J-P.
    ANNALS OF ONCOLOGY, 2024, 35 : S653 - S654
  • [8] Recent safety and efficacy findings from a phase 1b/2 open-label combination study of ASP-1929 photoimmunotherapy with anti-PD-1 therapy in EGFR-expressing advanced head and neck squamous cell carcinoma (HNSCC)
    Cognetti, David M.
    Curry, Joseph M.
    Civantos, Francisco F.
    Valentino, Joseph
    Agbaje-Williams, Mayowa
    Danesi, Hassan
    Dong, Haiying
    Larracas, Cristina
    Veresh, Bogdan
    Gillenwater, Ann M.
    Su, Shirley Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter, Open-label, Single-arm, phase 1b study
    Yang, Hang
    Sun, Peng
    Wang, Yu
    Wang, Xicheng
    Liu, Yanyan
    Peng, Jiyong
    Zhou, Hui
    Li, Yajun
    Zhang, Hong
    Hu, Jianbing
    Zhang, Bing
    Lin, Shunhuan
    Yang, Chunwei
    Li, Weidong
    Liu, Yanping
    Ji, Meng
    Zhao, Jinghua
    Xue, Jianfei
    Huang, Jiajia
    Li, Zhiming
    ORAL ONCOLOGY, 2025, 162
  • [10] DAHANCA 10-Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
    Overgaard, Jens
    Hoff, Camilla Molich
    Hansen, Hanne Sand
    Specht, Lena
    Overgaard, Marie
    Lassen, Pernille
    Andersen, Elo
    Johansen, Jorgen
    Andersen, Lisbeth Juhler
    Evensen, Jan Folkvard
    Alsner, Jan
    Grau, Cai
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 (01) : 12 - 19
12345